December 2, 2025

Morning Briefing

Published ~6:00 a.m. ET
Tags: #Markets #Economy #Policy

Overnight in Asia markets were jittery after comments from Bank of Japan Governor Kazuo Ueda stoked speculation of an earlier-than-expected policy tightening. Japanese 10-year JGB yields spiked to multi-year highs before a strong auction and demand from domestic investors helped calm bond markets; Tokyo equities were mixed while bank stocks outperformed. Regional indices otherwise posted patchy gains and losses as China and Hong Kong reacted to local data and sentiment. Financial Times+1

In Europe this morning the STOXX 600 and major bourses ticked higher overall, led by financials and a sharp move in German healthcare after Bayer rallied on news the U.S. government backed its Supreme Court petition over Roundup litigation — a legal development with clear earnings and liability implications for the group and peers. Eurozone flash inflation for November came in at 2.2% year-over-year, modestly above forecasts and keeping the ECB’s rate path on hold for now. Reuters+1

1) Global markets snapshot (Asia / Europe overnight)

  • Japan: yields rose to 17-year highs then steadied; Nikkei/Topix mixed; banks led. Financial Times
  • China/HK: uneven; CSI 300 modestly soft, Hang Seng roughly flat as tech swings continued. The Economic Times
  • Europe: STOXX 600 slightly up; DAX and CAC lifted by cyclical and select healthcare strength. Reuters

2) U.S. pre-market / early indicators

  • Futures are subdued and volatile — S&P and Nasdaq futures edging lower after a risk-off tone overnight. Commodities and yields are tracking the BOJ-driven global bond repricing. Markets are watching U.S. data this week for confirmation on the Fed’s odds for easing next year. Investopedia+1
  • Corporate headlines to watch: Bayer’s U.S. legal developments (possible Supreme Court review) could have cross-border litigation precedent effects; expect sector-level flow into insurers/chemicals. Reuters

3) Crypto market briefing & outlook

Cryptocurrency markets slid sharply overnight, with Bitcoin down double digits from recent highs before a modest rebound; total market cap plunged by hundreds of billions as liquidations and risk-off flows hit the space. Volatility remains elevated — macro drivers (higher global yields, weaker risk appetite) are dominating fundamentals for now. Short term: expect continued correlation with risk assets and heightened sensitivity to macro prints and regulatory headlines. TradingView+1

4) Key policy / regulatory developments

  • U.S. Solicitor General filed to support Bayer’s petition arguing federal preemption in Roundup cases — a development that could materially reduce litigation exposure if the Supreme Court grants review and rules in Bayer’s favor. That legal pivot is moving share prices and may affect liability provisions across the chemicals/agri sector. Reuters
  • Eurozone inflation tick higher reinforces ECB’s “hold” messaging for now — implications: curve dynamics in EUR vs. USD and timing of any future cuts have shifted slightly. European Commission

What to watch today

  1. U.S. ADP / private payrolls and ISM services (timing dependent) — labor/inflation implications.
  2. Fed speakers (several regional presidents this week) — market-moving tone on cuts.
  3. Corporate: any follow-through on Bayer/Supreme Court filings; major tech earnings reaction.
  4. Crypto on-chain liquidations and major exchange flows — watch derivatives open interest.
  5. Oil inventory print / energy headlines — geopolitical supply signals remain relevant.

Quick takeaways

  • BOJ-linked bond repricing set the overnight risk tone; JGB yields and yen moves are driving cross-asset reactions. Financial Times
  • Europe held up on financials and a Bayer legal boost; eurozone inflation surprised slightly hotter at 2.2%. Reuters+1
  • U.S. futures cautious — investors await key data and Fed commentary for directional clarity. Investopedia
  • Crypto remains in risk-off mode — expect outsized intraday volatility and spillover to risk assets. TradingView+1
  • Watch legal/regulatory moves (Bayer/Supreme Court) — these can quickly reprice sector risk and provisions. Reuters

— The Capitol Advisor team